Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cardiome Pharma Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

26 Aug 2016 Reuters Investment Profile 12 $20.00

Cardiome Pharma Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

27 Aug 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Cardiome Pharma Corp (COM-T)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

30 Aug 2016 Thomson Reuters Stock Report 11 $25.00

Will Cardiome Pharma Corp Bounce Back?

30 Aug 2016 Sadif Analytics Prime 12 $25.00

"The Economy Matters" Report for COM: the economy's impact on COM's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

29 Aug 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

ValuEngine Rating and Forecast Report for CRME

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

28 Aug 2016 ValuEngine, Inc. 11 $25.00

Cardiome Pharma

27 Aug 2016 S&P Capital IQ Quantitative Report 10 $115.00

CARDIOME PHARMA CP (CRME=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

27 Aug 2016 Pechala's Reports 2 $25.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CARDIOME PHARMA CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

26 Aug 2016 Jefferson Research 11 $20.00

Company Snapshot - Cardiome Pharma Corp

Five Directors at Cardiome Pharma Corp bought/maiden bought 63,213 shares at between 3.133USD and 3.240USD. The significance ...

16 Aug 2016 Directors Deals Ltd. 1 $12.00